Martin PM - Search Results

1

[Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: martin pm. Pathol Biol (Paris). 2000 Nov;48(9):825-31. Pathol Biol (Paris). 2000. PMID: 11141918 French.

2

[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].

Bouchet C, Spyratos F, Martin PM, Hacène K, Gentile A, Oglobine J. Bouchet C, et al. Among authors: martin pm. Bull Cancer. 1994 Sep;81(9):770-9. Bull Cancer. 1994. PMID: 7703566 French.

3

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

Bouchet C, Spyratos F, Martin PM, Hacène K, Gentile A, Oglobine J. Bouchet C, et al. Among authors: martin pm. Br J Cancer. 1994 Feb;69(2):398-405. doi: 10.1038/bjc.1994.74. Br J Cancer. 1994. PMID: 8297742 Free PMC article.

4

Dissemination risk index based on plasminogen activator system components in primary breast cancer.

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: martin pm. J Clin Oncol. 1999 Oct;17(10):3048-57. doi: 10.1200/JCO.1999.17.10.3048. J Clin Oncol. 1999. PMID: 10506599

5

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Foucré D, Bouchet C, Hacène K, Pourreau-Schneider N, Gentile A, Martin PM, Desplaces A, Oglobine J. Foucré D, et al. Among authors: martin pm. Br J Cancer. 1991 Nov;64(5):926-32. doi: 10.1038/bjc.1991.428. Br J Cancer. 1991. PMID: 1931618 Free PMC article.

6

Multiparametric prognostic evaluation of biological factors in primary breast cancer.

Spyratos F, Martin PM, Hacène K, Romain S, Andrieu C, Ferrero-Poüs M, Deytieux S, Le Doussal V, Tubiana-Hulin M, Brunet M. Spyratos F, et al. Among authors: martin pm. J Natl Cancer Inst. 1992 Aug 19;84(16):1266-72. doi: 10.1093/jnci/84.16.1266. J Natl Cancer Inst. 1992. PMID: 1640487

7

Prognostic factor clustering in breast cancer: biology or chronology?

Tubiana-Hulin M, Hacène K, Martin PM, Spyratos F. Tubiana-Hulin M, et al. Among authors: martin pm. Eur J Cancer. 1995;31A(2):282-3. doi: 10.1016/0959-8049(94)00414-z. Eur J Cancer. 1995. PMID: 7718338 No abstract available.

8

Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.

Spyratos F, Martin PM, Hacène K, Andrieu C, Romain S, Floiras JL, Magdelénat H. Spyratos F, et al. Among authors: martin pm. Breast Cancer Res Treat. 1994 Jan;29(1):85-95. doi: 10.1007/BF00666184. Breast Cancer Res Treat. 1994. PMID: 8018965 Clinical Trial.

9

Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.

Romain S, Spyratos F, Lainé-Bidron C, Bouchet C, Guirou O, Martin PM, Oglobine J, Magdelénat H. Romain S, et al. Among authors: martin pm. Eur J Clin Chem Clin Biochem. 1995 Sep;33(9):603-8. Eur J Clin Chem Clin Biochem. 1995. PMID: 8611670

10

[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].

Martin PM, Romain S, Spyratos F, Spitalier JM, Ayme Y, Brandone H, Bressac C, Hans D, Jacquemier J, Hacene K, et al. Martin PM, et al. Bull Cancer. 1991;78(8):709-23. Bull Cancer. 1991. PMID: 1932838 Clinical Trial. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters